ATE15108T1 - Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung. - Google Patents

Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung.

Info

Publication number
ATE15108T1
ATE15108T1 AT81302036T AT81302036T ATE15108T1 AT E15108 T1 ATE15108 T1 AT E15108T1 AT 81302036 T AT81302036 T AT 81302036T AT 81302036 T AT81302036 T AT 81302036T AT E15108 T1 ATE15108 T1 AT E15108T1
Authority
AT
Austria
Prior art keywords
detection
cancer
evaluation
methods
composition suitable
Prior art date
Application number
AT81302036T
Other languages
English (en)
Inventor
Barry Ira Bluestein
Gerald Odstrchel
Albert August Luderer
Original Assignee
Corning Glass Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corning Glass Works filed Critical Corning Glass Works
Application granted granted Critical
Publication of ATE15108T1 publication Critical patent/ATE15108T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5757—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofoetal proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT81302036T 1980-05-08 1981-05-08 Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung. ATE15108T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14792880A 1980-05-08 1980-05-08
EP81302036A EP0040058B1 (de) 1980-05-08 1981-05-08 Verfahren zum Nachweis von onkofötalen Antigenen, zum Nachweis von Krebs, zur Beurteilung der Krebstherapie und für diesen Zweck geeignete diagnostische Zusammenstellung

Publications (1)

Publication Number Publication Date
ATE15108T1 true ATE15108T1 (de) 1985-09-15

Family

ID=22523493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81302036T ATE15108T1 (de) 1980-05-08 1981-05-08 Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung.

Country Status (5)

Country Link
EP (1) EP0040058B1 (de)
JP (1) JPS576364A (de)
AT (1) ATE15108T1 (de)
CA (1) CA1166957A (de)
DE (1) DE3171892D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
JPS5915858A (ja) * 1982-07-16 1984-01-26 Otsuka Pharmaceut Co Ltd 腫瘍関連抗原特異的免疫複合体の測定法
CA2129368C (en) * 1992-03-27 2002-01-22 Linda S. Schmidt Assay verification control for analytical methods
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
WO1994024569A1 (en) * 1993-04-22 1994-10-27 Baxter Diagnostics Inc. Tumor marker control
EP1225233A3 (de) * 2001-01-23 2003-01-08 Amsterdam Support Diagnostics B.V. Mittel und Methoden für die Abschätzung einer Behandlung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US3988115A (en) * 1975-09-18 1976-10-26 Modabber Farrokh Z Diagnostic method for determining pathological condition by antigen-combining capacity of lymphocytes
US4144031A (en) * 1976-04-19 1979-03-13 International Radioimmune Systems, Inc. Cell test for detecting human chorionic gonadotropin
US4116776A (en) * 1976-04-19 1978-09-26 International Radioimmune Systems, Inc. Diagnostic blood test and kit for detecting human chorionic gonadotropin
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent

Also Published As

Publication number Publication date
JPS576364A (en) 1982-01-13
EP0040058A1 (de) 1981-11-18
EP0040058B1 (de) 1985-08-21
CA1166957A (en) 1984-05-08
JPH0121909B2 (de) 1989-04-24
DE3171892D1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
EP0335244A3 (en) Solid-phase analytical device and method for using same
ES8405156A1 (es) Procedimiento para la produccion de equipos de analisis inmulogicos.
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
IL49685A0 (en) Specific binding assay method for determining the concentration of materials and reagent means therefor
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
ES2035317T3 (es) Un metodo para la deteccion y el analisis de celulas hematopoyeticas en una muestra.
ATE12010T1 (de) Verfahren zur bestimmung von antigen-antikoerper- reaktionen und reagens hierfuer.
ATE175025T1 (de) Verfahren, reagenzien und testkits zum nachweis von subpopulationen biologischer substanzen
ATE37095T1 (de) Fluoreszenz-untersuchungsverfahren zur bluttypenbestimmung.
DE3684880D1 (de) Verfahren und apparat zur bestimmung des antikoerperinhalts von blut.
ATE15108T1 (de) Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung.
ES483606A1 (es) Metodo y su correspondiente kit de prueba para la deteccion-y-o determinacion de una inmunoglobulina especifica antige- nica.
DE69513649D1 (de) Verfahren zum nachweis der gegenwart einer mykobakterien-spezies und testsatz sowie antikörpes zur verwendung in diesem verfahren
SE7714034L (sv) Forfarande for enzymkopplad immunoanalys
DE3485265D1 (de) Verfahren zur bestimmung eines polyvalenten antigens und reagenz hierfuer.
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
ATA261687A (de) Laktoferrin enthaltendes inkubationsmedium für festphasen-immunometrische verfahren und seine verwendung
DE3767659D1 (de) Verfahren und testelement zum auffinden von zellaesionen.
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
EP0348144A3 (de) Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten
ATE64466T1 (de) Immuntest.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
ATE42002T1 (de) Verfahren zur immunochemischen bestimmung von hepatitis-b-core-antigenen.
JPS56162056A (en) Method for determining immunity using immunoglobulin fragment mixture sensitizing latex particles
HU912200D0 (en) Method for immunological indication

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee